ZPL-5212372 / Novartis 
Welcome,         Profile    Billing    Logout  
 3 Diseases   1 Trial   1 Trial   4 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ZPL-5212372 / Novartis
2016-000376-26: A study to determine the effects of up to 2 weeks of treatment with an ointment applied to the skin containing the drug ZPL-5212372 in healthy volunteers and adult patients with moderate to severe atopic dermatitis.

Ongoing
1/2
54
Europe
ZPL-5212372, Ointment
Ziarco Pharma Ltd, Ziarco Pharma Ltd
Atopic Dermatitis, Atopic Dermatitis, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 

Download Options